Keep the details together.
- Product scope
- Trulicity: specified type 2 diabetes populations.
- Route and preparation
- Subcutaneous injection.
- Mechanism
- GLP-1 receptor agonist fusion protein.
- Evidence
- Randomized studies.
- Limits of the reference
- No weight-management indication.
- Safety context
- Not recommended for severe gastroparesis.
A note on reading the evidence.
Make a small identity card for the item behind a claim: the product description, its preparation, and how it was given. Then compare that card with the description in the research report. If the names look similar but other details differ, note the mismatch instead of treating the citation as an automatic match. An ingredient name is a useful place to start checking, but it does not complete the check. The question for discussion is what evidence would justify carrying a conclusion from the tested item to the item being described.
Questions to open a conversation.
- Which product details connect the claim to the research being cited?
- Are the preparation and method of administration described the same way?
- What supports applying the conclusion when those product details differ?
Source reading.
- TRULICITYNLM · Checked